cancer gene therapy (Oxford BioMedica)

N/A

Report date: 2026/01/27 17:57:27

Base Information

Drug Namecancer gene therapy (Oxford BioMedica)
Drug Alias Namecancer gene therapy (CAMR)cancer gene therapy (Oxford BioMedica/CAMR)
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesOxford Biomedica PLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOxford Biomedica PLC
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A